ArticleCancer cell international2022

Combinatorial targeting of menin and the histone methyltransferase DOT1L as a novel therapeutic strategy for treatment of chemotherapy-resistant ovarian cancer.

Elena Alexandrova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.